Furanoditerpenoids from Tinospora crispa
Journal of Natural Products, 2010, Vol. 73, No. 4 547
flask, and kept in a 5% CO
+
7
(
3 (58), 61 (36), 60 (58), 55 (56); HRESIMS m/z 551.2133 [M + H]
calcd for C27 12, 551.2123).
Methyl (2R,7S,8S)-8-[(2S)-2-(3,4-dihydroxy-2,5-dimethoxytet-
rahydro-3-furanyl)-2-hydroxyethyl]-2,8-dimethyl-10-oxo-11-oxat-
2
incubator at 37 °C. Exponentially growing
H
35
O
cells were harvested, counted with hemocytometer, and diluted with
4
DMEM. Cell cultures at the concentration of 3 × 10 cells/mL were
prepared and introduced (100 µL/well) into 96-well plates. After
overnight incubation, the medium was removed and 200 µL of fresh
medium was added with different concentrations of compounds (1-100
µM). After 72 h, 50 µL of MTT (2 mg/mL) was added to each well
and incubated further for 4 h. Subsequently, 100 µL of DMSO was
added to each well. The extent of MTT reduction to formazan within
cells was calculated by measuring the absorbance at 540 nm, using a
microplate ELISA reader (Spectra Max Plus, Molecular Devices, CA).
The cytotoxicity was recorded as the concentration causing 50% growth
inhibition for both PC-3 and 3T3 cells. Doxorubicin (IC50 0.912 (
0.12 µM) and cycloheximide (IC50 0.26 ( 0.04 µM) were used as
positive control for the PC-3 and 3T3 cell lines, respectively.
2,7
ricyclo[7.2.1.0 ]dodec-3-ene-3-carboxylate (rumphiol E) (4): amor-
2
2
phous, colorless solid; [R]
D
3
+27.5 (c 0.04, CHCl ); UV (MeOH) λmax
(
log ε) 242 (2.32) nm; IR (KBr) νmax 3551, 3505, 3394, 1745, 1701
-
1
1
13
cm ; H and C NMR (CDCl
3
), see Table 4; EIMS m/z 307 (94),
2
75 (47), 203 (14), 185 (21), 119 (16), 85 (100), 95 (8), 94 (95), 93
+
(
35 10
29), 81 (12); HRESIMS m/z 471.2312 [M + H] (calcd for C23H O ,
4
71.2225).
5R,6R,8S,9R,10S,12S)-15,16-Epoxy-2-oxo-6-O-(ꢀ-D-glucopyrano-
syl)-cleroda-3,13(16),14-trien-17,12-olid-18-oic acid methyl ester (5):
(
2
7
amorphous, colorless, gummy solid; [R]
D
+260.8 (c 0.046, MeOH);
UV (MeOH) λmax (log ε) 225 (3.72), 216 (4.35), 205 (4.42) nm; IR
-
1
1
13
(
KBr) νmax 3421, 1718, 1674 cm ; H and C NMR (CD
3
OD), see
Tables 2 and 3; HRESIMS m/z 549.2171 [M + H] (calcd for
12, 549.2123).
2R,5R,6S,9S,10S,12S)-15,16-Epoxy-2-hydroxy-6-O-(ꢀ-D-glucopy-
ranosyl)-cleroda-3,7,13(16),14-tetraen-17,12-olid-18-oic acid methyl
+
Acknowledgment. We are grateful to the IDB (The Islamic
Development Bank, Jeddah, Saudi Arabia) and COMSTECH, Islama-
bad, Pakistan, for financial support (M.I.C.) for the research project
entitled, “Phytochemical, Pharmacological and Toxicological Studies
on Medicinal Plants of Sudan and Pakistan”.
27 35
C H O
(
2
2
ester (6): amorphous, colorless solid; [R]
D
+10.9 (c 0.06, MeOH);
UV (MeOH) λmax (log ε) 208 (3.82) nm; IR (KBr) νmax 3430, 1725,
Supporting Information Available: The H, 13C NMR, COSY,
HMBC, HMQC, and NOESY/ROESY spectra of new compounds 1-9.
These materials are available free of charge via the Internet at http://
pubs.acs.org.
1
-
1
1
13
1
664 cm ; H and C NMR (CD
3
OD), see Table 4; EIMS m/z 388
(
(
9), 356 (6), 218 (38), 147 (45), 119 (43), 95 (64), 94 (60), 81 (71), 55
+
+
+
100); FABMS m/z 551 [M + H] , 573 [M + Na] , 389 [M - 162] ,
+
+
3
71 [M - 180] ; HRESIMS m/z 573.1980 [M + Na] (calcd for
12Na, 573.1948).
5R,6S,9S,10S,12S)-15,16-Epoxy-2-oxo-6-O-(ꢀ-D-glucopyranosyl)-
cleroda-3,7,13(16),14-tetraen-17,12-olid-18-oic acid methyl ester (7):
27 34
C H O
References and Notes
(
(1) Siddiqi, M. A.; Nasir, E.; Ali, S. I. Flora of West Pakistan; Ferozsons:
Karachi, 1974; No. 74, p 5.
(2) Noor, H.; Ashcroft, S. J. H. J. Ethnopharmacol. 1998, 62, 7–13.
(3) Perry, L. M. Medicinal Plants of East and South East Asia; MIT Press:
Cambridge, MA, 1980; p 268.
2
2
amorphous, colorless solid; [R]
D
-14.2 (c 0.01, MeOH); UV (MeOH)
λ
max (log ε) 210 (3.70), 201 (3.81) nm; IR (KBr) νmax 3425, 1723, 1667
-
1
1
13
cm ; H and C NMR (CD
3
OD), see Table 4; EIMS m/z 386 (19),
3
54 (9), 309 (6), 216 (19), 202 (30), 145 (46), 135 (37), 95 (50), 94
+
(4) Herbal Medicine Research Group. Compendium of Medicinal Plants
Used in Malaysia; Institute for Medical Research, Malaysia: Kuala
Lumpur, 2002; Vol. 2, pp 392-393.
(
70), 81 (69), 73 (100); HRESIMS m/z 549.1976 [M + H] (calcd for
12, 547.1967).
3R,4R,5R,6S,8R,9S,10S,12S)-15,16-Epoxy-3,4-epoxy-6-O-(ꢀ-D-
glucopyranosyl)-cleroda-3,13(16),14-trien-17,12-olid-18-oic acid meth-
27 33
C H O
(
(
5) Singh, S. S.; Pandey, S. C.; Srivastava, S.; Gupta, V. S.; Patro, B.;
Ghosh, A. C. Indian J. Pharmacol. 2003, 35, 83–91.
2
7
yl ester (8): amorphous, gummy solid; [R]
UV (MeOH) λmax (log ε) 222 (4.46), 203 (4.65) nm; IR (KBr) νmax
3
3
1
6
D
+135.1 (c 0.07, MeOH);
(6) Chintalwar, G.; Jain, A.; Sipahimalani, A.; Banerji, A.; Sumariwalla,
P.; Ramakrishnan, R.; Sainis, K. Phytochemistry 1999, 52, 1089–1093.
(7) Shen, Y. C.; Cheng, Y. B.; Ahmed, A. F.; Lee, C. L.; Chen, S. Y.;
Chien, C. T.; Kuo, Y. H.; Tzeng, G. L. J. Nat. Prod. 2005, 68, 1665–
-1
1
13
447, 1714, 1635 cm ; H and C NMR (CD OD), see Tables 2 and
3
; EIMS (70 eV) m/z (%) 373 (7), 341 (2), 323 (2), 205 (6), 194 (100),
19 (16), 95 (17), 94 (19), 93 (7), 91 (28), 81 (19), 73 (24), 61 (10),
0 (18), 59 (9), 55 (33); HRESIMS m/z 553.2255 [M + H] (calcd for
1
668.
8) Maurya, R.; Wazir, V.; Kapil, R. S. J. Indian Chem. Soc. 1994, 71,
61–364.
(
(
+
3
27 37
C H O12, 553.2280).
9) Martin, T. S.; Ohtani, K.; Kasai, R.; Yamasaki, K. Phytochemistry
1995, 40, 1729–1736.
(10) Atta-ur-Rahman; Ahmed, S.; Ali, S. S.; Shah, Z.; Choudhary, M. I.
(1R,4S,5R,8S,9R,10S,12S)-15,16-Epoxy-4-O-(ꢀ-D-glucopyranosyl)-
cleroda-2,13(16),14-triene-17(12),18(1)-diolide (9): amorphous, color-
2
7
Tetrahedron 1994, 50, 12109–12112.
11) Fukuda, N.; Yonemitsu, M.; Kimura, T. Liebigs Ann. Chem. 1993,
491–495.
less, gummy solid; [R]
D
-87.0 (c 0.05, MeOH); UV (MeOH) λmax
(
(
log ε) 224 (3.46), 213 (4.82), 207 (4.82) nm; IR (KBr) νmax 3420,
751, 1716 cm ; H and C NMR (CD OD), see Tables 2 and 3;
3
-
1
1
13
1
(
12) Martin, T. S.; Ohtani, K.; Kasai, R.; Yamasaki, K. Phytochemistry
EIMS m/z 314 (34), 281 (3), 252 (3), 220 (13), 206 (39), 134 (41),
21 (88), 119 (16), 108 (98), 107 (39), 97 (23), 95 (50), 94 (56), 93
30), 91 (66), 81 (100), 73 (86), 60 (32), 55 (46); HRESIMS m/z
1
996, 42, 153–158.
1
(13) Akhila, A.; Rani, K.; Thakur, R. Phytochemistry 1991, 30, 2573–2576.
14) Manabe, S.; Nishino, C. Tetrahedron 1986, 42, 3461–3470.
(
(
+
5
21.2043 [M + H] (calcd for C26
Cytotoxicity Assays. Cytotoxicity of the compounds was evaluated
in a 96-well flat-bottomed microplate by using a standard MTT (3-
4,5-dimethylthiazole-2-yl]-2,5-diphenyltetrazolium bromide) colori-
H
34
O
11, 521.2017).
(15) Khan, M. A.; Gray, A. I.; Waterman, P. G. Phytochemistry 1989, 28,
273–275.
(16) Pavia, D. L.; Lampan, G. M.; Kriz, G. S. Introduction to Spectroscopy;
W. B. Saunders Co.: Philadelphia, 1979; pp 67-68.
(17) Fukuda, N.; Yonemitsu, M.; Kimura, T.; Hachiyama, S.; Miyahara,
K.; Kawasaki, T. Chem. Pharm. Bull. 1985, 33, 4438–4444.
[
1
8
metric assay. For this purpose, PC-3 cells (human prostate cancer)
and 3T3 cells (mouse fibroblasts) were cultured in Dulbecco’s modified
(
18) Mosmann, T. J. Immunol. Methods 1983, 65, 55–63.
Eagle’s medium (DMEM), supplemented with 5% fetal bovine serum
3
(
FBS), 100 IU/mL pencillin, and 100 µg/mL streptomycin in a 25 cm
NP900551U